Investors Count
4Funding, Valuation & Revenue
1 Fundings
GammaMabs Pharma's latest funding round was a Series A for on September 30, 2013.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
9/30/2013 | Series A |
Date | 9/30/2013 |
|---|---|
Round | Series A |
Amount | |
Investors | |
Valuation | |
Revenue | |
Sources |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
GammaMabs Pharma Investors
4 Investors
GammaMabs Pharma has 4 investors. CDC Entreprises invested in GammaMabs Pharma's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/30/2013 | 9/30/2013 | 1 Series A | Venture Capital | France | ||
Venture Capital | France | |||||
Diversified Financial Services | France | |||||
Corporation | France |
First funding | 9/30/2013 | |||
|---|---|---|---|---|
Last Funding | 9/30/2013 | |||
Investor | ||||
Rounds | 1 Series A | |||
Board Seats | ||||
Type | Venture Capital | Venture Capital | Diversified Financial Services | Corporation |
Location | France | France | France | France |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.